Stocks
Axsome Therapeutics (AXSM) P/E US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -10.9 | 0.00 | 0.00 | -14.1 | -49.6 | -46.0 | ||
| Changes by years, y/y, % | -63% | -100% | +251% | +11.0% | |||||
Axsome Therapeutics. P/E
Axsome Therapeutics. P/E, changes, %
Axsome Therapeutics (AXSM) P/E US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/E | ? | -20.5 | -20.9 | -26.5 | -50.5 | -46.0 | -46.0 | |
| Changes by years, y/y, % | +90% | +253% | +124% | |||||
| Changes by quarters, q/q, % | +43% | +2% | +27% | +91% | -9% | |||
